Navigation Links
HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
Date:6/12/2009

BIRMINGHAM, Ala., June 12 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) announced today that its board of directors has declared a regular quarterly dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on July 15, 2009, to holders of record on July 1, 2009.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitative healthcare services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves patients through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitative healthcare services and can be found on the Web at www.healthsouth.com.

    Media Contact:
    Andy Brimmer, 205-410-2777

    Investor Relations Contact:
    Mary Ann Arico, 205-969-6175
    maryann.arico@healthsouth.com


'/>"/>
SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HealthSouth Announces Date of 2009 Second Quarter Earnings Conference Call
2. Court Rules in Favor of HealthSouth in Litigation Involving General Medicine, P.C.
3. HealthSouth to Present at 34th Annual Deutsche Bank Health Care Conference
4. HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009
5. HealthSouth to Present at Bairds 2009 Growth Stock Conference
6. HealthSouth to Hold Annual Stockholder Meeting
7. HealthSouth Announces Date of 2009 First Quarter Earnings Conference Call
8. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
9. HealthSouth to Present at Barclays Capital Global Healthcare Conference
10. HealthSouth Issues Preliminary Comments on the Presidents Healthcare Budget Proposal and Announces Plans to Host a Conference Call
11. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Jacksonville, FL (PRWEB) , ... March 22, 2017 ... ... (ASPC) convened experts to create a PCSK9 inhibitor prior authorization (PA) form for ... high cholesterol. It is one of the helpful tools published as part of ...
(Date:3/22/2017)... ... 22, 2017 , ... Wash Tower Ltd. has released a series of six ... the world's first standalone constant pressure bidet. , The videos in the series titled ... https://www.washtower.com as well as on its social media pages. , Each video stars ...
(Date:3/22/2017)... ... 22, 2017 , ... University Orthopedics (UOI) today announced the ... Hand, Upper Extremity and Microvascular Surgery at Newport Hospital. Dr. Bragdon specializes in ... and Hand Surgery. , As the leader of comprehensive orthopedic care in ...
(Date:3/22/2017)... ... March 22, 2017 , ... SNL Insurance and Financial, a ... business owners in the greater Hampton Roads area, is embarking on a community ... Life event. , Each year, hundreds of people living in the South Hampton ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... planning assistance, and related services to families and business owners in the greater ... with the Leukemia & Lymphoma Society. , Every 3 minutes, someone in America ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017 Under the impetus ... packaging market size increased year by year at ... to 2021, the market size will maintain the ... to outnumber RMB140 billion in 2021, thanks to ... development of biological agents and supporting policies. ...
(Date:3/22/2017)... March 22, 2017 New Jersey,s ... of patient harm and saved $641 million in healthcare ... in a national quality improvement program. ... for Patients-New Jersey, part of a national initiative from ... selected the New Jersey Hospital Association and its affiliate, ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets ... Point Inhibitors Market & Clinical Pipeline Insight 2022" drug ... ... & Clinical Pipeline Insight 2022 report gives comprehensive insight on ... of immune check point inhibitors as main streamline drugs in ...
Breaking Medicine Technology: